Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Privia Health Group (PRVA)

Privia Health raises 2025 guidance as Q2 revenue rises 23.4% and GAAP profit falls

Mixed Impact 4 of 5 earnings Written later

Privia Health reported second-quarter 2025 total revenue of $521.2 million, up 23.4% from a year earlier, and raised its full-year 2025 guidance. GAAP net income attributable to Privia shareholders fell to $2.7 million from $3.5 million, while non-GAAP adjusted net income per diluted share rose to $0.24 from $0.19. The results are preliminary and unaudited until the company's Form 10-Q is filed.

Key points

  • Q2 2025 total revenue was $521.2 million, versus $422.3 million in Q2 2024, up 23.4%.
  • Q2 net income attributable to Privia shareholders was $2.7 million, or $0.02 per diluted share, versus $3.5 million, or $0.03, a year earlier.
  • Q2 Adjusted EBITDA was $29.0 million, up 31.6% from $22.0 million.
  • Updated FY 2025 guidance includes GAAP revenue of $1.8 billion to $1.9 billion and Adjusted EBITDA of $105 million to $110 million, both above the high end of the prior range.

The filing

CompanyPrivia Health Group (PRVA)
Form8-K, current report
Filed with the SECAug 7, 2025, 6:10 AM ET
Accession number0001759655-25-000091

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:49 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 07, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.